It's Watson Pharmaceuticals and Wyeth in the ring, as Watson filed for FDA approval to sell a generic version of Lybrel, a birth control pill, and Wyeth responded by suing for patent infringement. Report [1], Report [2]
It's Watson Pharmaceuticals and Wyeth in the ring, as Watson filed for FDA approval to sell a generic version of Lybrel, a birth control pill, and Wyeth responded by suing for patent infringement. Report [1], Report [2]
Links:
[1] http://money.cnn.com/news/newsfeeds/articles/djf500/200803131634DOWJONESDJONLINE001023_FORTUNE5.htm
[2] http://www.boston.com/business/healthcare/articles/2008/03/13/wyeth_sues_watson_in_patent_dispute/